Serum platelet-activating factor acetylhydrolase activity in normal pregnancy and preeclampsia

Hypertension in Pregnancy

Volumn 15, Issue 1, 1996, Pages 51-59

  Matsubara, Keiichi ^a   Yano, Juri ^a   Kitagawa, Hiroyuki ^a   Ochi, Hiroshi ^a   Suginami, Hiroshi ^b   Sagawa, Norimasa ^c   Matsuura, Shumpei ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Hypertension; Platelet activating factor acetylhydrolase (PAF AH); Platelet activating factor (PAF); Preeclampsia; Pregnancy

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY;

EID: 0029905398     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015688     Document Type: Article

References (27)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
2. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4: 700-8.
3. Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exper Hyper Pregnancy 1992; B11(2&3):117-29.
4. Walsh SW. An imbalance in placental prostacyclin and thromboxane production. Am Obstet Gynecol 1985;152:335-40.
5. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 1972;136:1356-77.
6. Camussi G, Bussolino F, Tetta C, Piacibello W, Aglietta M. Biosynthesis and release of platelet-activating factor from human monocytes. Int Arch Allergy Appl Immunol 1983;70:245-51.
7. Turner-Gomes SO, Bourdreau N, Rabinovitch M. Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells. Prostaglandins 1991;41:463-72.
8. Issekutz AC, Szpejda M. Evidence that platelet activating factor may mediate some acute inflammatory responses. Lab Invest 1986;54:275-81.
9. Hirafuji M, Shinoda H. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet activating factor in vitro. Br J Pharmacol 1991;103:1333-8.
10. Blank ML, Hall MN. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 1983;113:666-71.
11. Crook JE, Mroczkowski PJ, Cress EE, Blank ML, Snyder F. Serum platelet activating factor acetylhydrolase activity in white and black essential hypertensive patients. Circulation 1986;74:II-329.
12. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 1990;110:529-40.
13. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs. J Pharmacol Exp Ther 1984;228:510-22.
14. Dembinska-kiec A, Peskar BA, Muller MK, Peskar BM. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. Prostaglandins 1989;37:69-91.
15. Rodrigues A, Hofmeyr GJ, Sonnendecker EWW, Atkunson PM. Hypothesis: a central role for platelet activating factor in the pathogenesis of pre-eclampsia. Med Hypotheses 1989;28:285-6.
16. Benveniste J, Prefolani M. Paf-acether (platelet-activating-factor): its role in inflammation. Adv Inflam Res 1985;10:7-19.
17. Pinckard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitized basophils. J Immunol 1979;123:1847-57.
18. Farr RS, Wardlow ML, Cox CP, Meng KE, Greene DE. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Fed Proc 1983;42: 3120-2.
19. Elstad MR, Stafforini DM, McIntyre TM, Prescott SM, Zimmerman GA. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. J Biol Chem 1989;264:8467-70.
20. Miwa M. Catabolism of PAF and its regulation. Protein, Nucleic Acid and Enzyme 1991;36:352-62.
21. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259(Cell Physiol)28:c697-c708.
22. Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Mizuno S, et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins 1988;35(3):685-98.
23. Benedetto C, Massobrio M, Bertini E, Abbondanza M, Enrieu N, Tetta C. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. Am J Obstet Gynecol 1989;160:100-4.
24. Maki N, Magness RR, Miyaura S, Gant NF, Johnston JM. Platelet-activating factor acetylhydrolase activity in normotensive and hypertensive pregnancies. Am J Obstet Gynecol 1993;168:50-4.
25. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap III LC, eds. Hypertensive Disorders in Pregnancy: Williams Obstetrics. 19th ed. Appleton and Lange, 1993:763-6.
26. Stafforini DM, Prescott SM, McIntyre TM. Human plasma platelet-activating factor acetylhydrolase. J Biol Chem. 1987;262:4223-30.
27. Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. J Clin Invest 1988; 82:1983-91.